Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 6Frailty 4Lymphoma 3Prostatic Neoplasms 2Ovarian Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Prostate Cancer Cured 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lung Neoplasms 1HER2 Positive Breast Carcinoma 1Colorectal Neoplasms 1

Interventions

neratinib 1Geriatric Assessment 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HER2 Positive Breast Carcinoma × Geriatric Assessment × Clear all
NCT02673398 2023-06-18

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

City of Hope Medical Center

Phase 2 Completed
25 enrolled 18 charts
Breast

HER2 Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡